4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-010810
Chief Operating Officer gave up 744 shares (to pay taxes)
- Chief Operating Officer acquired 1,791 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2025-03-31 | Option exercise | +1,791 | 42,729 | D | ||
| Cittadine Andrew Chief Operating Officer | 2025-03-31 | Shares withheld for taxes | −744 | $36.41 | $27,089 | 41,985 | D |
| Derivatives | |||||||
| Cittadine Andrew Chief Operating Officer | 2024-03-31 | Option exercise · Restricted Stock Units | −1,791 | 49,864 | D | ||
Loading xslF345X05/rdgdoc.xml…